Anthony Hadden, MD
Neurosurgery · Bend, ORNPI 1396701504
Payments from drug & device makers
Across 490 payments — averaging $128.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$35K
- Abbott$25K
- Nevro Corp.$1K
- Stryker$502
- Boston Scientific$345
- Biocomposites Inc$163
- plus $868 from 10 others
What the payments were for
- Consulting fees$12,00026%
- Speaking & faculty fees$5,60012%
- Travel & lodging$15,22933%
- Food & beverage$13,56929%
- Education$890%
- Entertainment$1480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 123 | $34,642 |
| Abbott | 276 | $25,127 |
| Nevro Corp. | 54 | $1,446 |
| Stryker | 6 | $502 |
| Boston Scientific | 10 | $345 |
| Biocomposites Inc | 2 | $163 |
| Zimvie Inc. | 4 | $151 |
| Orthofix Medical, Inc. | 1 | $142 |
| Zimmer Biomet | 4 | $124 |
| Centinel Spine, LLC | 1 | $106 |
| Radius Health, Inc. | 2 | $92 |
| Providence Medical Technology, Inc. | 1 | $84 |
| Intrinsic Therapeutics | 2 | $81 |
| Si-bone, Inc. | 2 | $44 |
| Medtronic | 1 | $23 |
| Relievant Medsystems, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$14,217
- ALIF$11,104
- RISE-L$3,352
- Spine$3,352
- PROCLAIM$3,273
- Senza$643
- Excelsius - GPS$432
- ETERNA$405
- Omnia$336
- IVAS$313
- Proclaim IPG$254
- iGA$154
- PENTA$150
- Proclaim Family of SCS IPGs$142
- 7D Surgical System$142
- Stimulan$137
- Archon$130
- LATERALALIF$123
- Senza Spinal Cord Stimulation System$121
- Simplify Cervical Artificial Disc$113
How this compares
Too few neurosurgery providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 58 | $475 |
| Gabapentin | 67 | $411 |
| Methocarbamol | 20 | $303 |
| Methylprednisolone | 34 | $290 |
| Cyclobenzaprine Hcl | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in Bend
- Kent YundtBend$4K
- Maurice ColladaSalem$3K
- Donald RossMedford$0
- David HoakPortland$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.